AKBA vs SRE · rev $102.7M vs P/E 31, rev $13.70B
Akebia Ther (AKBA) versus Sempra Energy (SRE) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Sempra Energy (SRE) is a utilities - diversified company listed on US.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Latest reported SRE revenue for 2025-12-31 was $13.70B. Net income was $1.84B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
AKBA currently screens at market cap $260.1M. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
Not investment advice. Open the AKBA and SRE stock pages for the full models.
Not investment advice.